Senate affirms commitment to ending HIV/AIDS by 2030
S.Res. 522 — A resolution commemorating and supporting the goals of World AIDS Day. · Filed by Cory Booker (D-NJ) · Introduced Dec 2, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This Senate resolution commemorates World AIDS Day (December 1) and expresses support for global and domestic efforts to combat HIV/AIDS. It acknowledges the scale of the epidemic—40.8 million people living with HIV/AIDS worldwide, with disproportionate impact on communities of color in the U.S.—and endorses existing programs like PEPFAR, the Ryan White CARE Act, and the Global Fund, while calling for continued funding, expanded testing and treatment access, and stronger international coordination to achieve zero new transmissions, zero discrimination, and zero AIDS-related deaths by 2030.
Why we flagged it
This is a commemorative and advocacy resolution with no binding legislative mechanism—it expresses Senate support for existing HIV/AIDS programs and calls for continued public health action. It is purely a statement of policy intent and values, not a law or appropriation.
What the text implies
- Resolution does not appropriate funds or create new programs; it is a non-binding statement that may be used to signal legislative intent for future appropriations or policy decisions.
- Emphasis on PEPFAR and Global Fund suggests potential future advocacy for sustained or increased international AIDS funding, which may face budget constraints or political opposition.
The full analysis lists 3 implications of this text.
Who it affects
The resolution affirms public health commitments and calls for sustained funding for HIV prevention, treatment, and research that directly serve people living with HIV and at-risk populations. It highlights health disparities and advocates for equitable access to life-saving medications and services, benefiting vulnerable communities disproportionately affected by the disease.